Evidence map›Paper›PMID 41416953›Full record

ArticleEuropean journal of immunology2025

Serous Cavity Mast Cells Depend on the ROQUIN Paralogs.

Klaus Heger, Ali Masjedi, Assa Yeroslaviz, Theodor Zeng, Seren Baygün, Angela Vicente-Luque, Chia-I Lien, Lena Osswald, Dieter Saur, Daniel Kovacs and 1 more

Abstract read
In one paragraph

Article in European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Serous Cavity Mast Cells Depend on the ROQUIN Paralogs.European journal of immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Klaus HegerInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Ali MasjediInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Assa YeroslavizMax-Planck Institute of Biochemistry, Planegg, Germany.ORCID 0000-0001-9638-4026
Theodor ZengInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Seren BaygünInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Angela Vicente-LuqueInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Chia-I LienInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Lena OsswaldInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Dieter SaurCenter For Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.
Daniel KovacsInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Marc Schmidt-SupprianInstitute of Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells are evolutionarily ancient immune cells located at strategic entry points for pathogens and allergens. Allergen exposure activates signal transduction pathways resembling those downstream of antigen receptors in T and B lymphocytes, leading to mast cell degranulation and cytokine secretion. The paralogous RNA-binding proteins ROQUIN-1 and ROQUIN-2 prevent aberrant T cell activation and differentiation and are cleaved upon antigen receptor engagement. Here, we investigated their roles in connective tissue mast cells using conditional gene knockout in mice. We show that ROQUIN-1 and ROQUIN-2 are dispensable for skin mast cell development and maintenance, while they are essential for serosal mast cells residing in the peritoneal and pleural cavities. Concurrent ablation of both paralogs did not affect mast cell degranulation in vitro and in vivo, nor did it alter activation-induced secretion of TNF and IL-6, cytokines that are regulated by ROQUIN proteins in other cell types. Furthermore, we globally define ROQUIN-regulated mRNAs in mast cells, and validate Runx1t1 and Ebi3 as indirect and Lfng as direct ROQUIN targets. Collectively, our results highlight the essential function of ROQUIN in connective tissue mast cells in serosal cavities.

Indexed as

Mast CellsRNA-Binding ProteinsUbiquitin-Protein LigasesAnimalsCell DegranulationInterleukin-6MiceMice, Inbred C57BLMice, KnockoutSignal TransductionSkinInterleukin-6Rc3h1 protein, mouseRNA-Binding ProteinsUbiquitin-Protein Ligasesconnective tissue mast cellsdegranulationposttranscriptional gene regulationpro‐inflammatory cytokinesROQUIN paralogsserous cavities

Identifiers

PMID41416953
PMCPMC12716222

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.